Aviva PLC Deciphera Pharmaceuticals, Inc. Transaction History

Aviva PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$32.73 - $47.95 $906,850 - $1.33 Million	-27,707 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$40.39 - $56.73 $141,001 - $198,044	3,491 Added 14.42%	27,707 $1.24 Million
Q4 2020 Feb 10, 2021	SELL	$51.77 - $66.18 $1.02 Million - $1.3 Million	-19,631 Reduced 44.77%	24,216 $1.38 Million
Q3 2020 Nov 12, 2020	BUY	$43.8 - $58.16 $211,422 - $280,738	4,827 Added 12.37%	43,847 $2.25 Million
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $1.45 Million - $2.54 Million	39,020 New	39,020 $2.33 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.